VivoSim Labs VIVS
NASDAQ VIVS
$0.28 +0.00 (+1.77%)
As of: Aug 21, 2026 · 2:40 PM EDT

VivoSim Labs (VIVS) Notes Payables (2011 - 2016)

VivoSim Labs (VIVS) posted quarterly Notes Payables of $8000.0 for Q4 2016, down 42.86% year-over-year from $14000.0 in Q1 2016, and down 11.11% quarter-over-quarter from $9000.0 in Q3 2016.

VivoSim Labs (VIVS) Notes Payables (2011 - 2016) Analysis & Trends

VivoSim Labs' Notes Payables history runs 6 years deep, the most recent figure standing at $8000.0 for Q4 2016.

  • In Q4 2016, Notes Payables fell 42.86% year-over-year to $8000.0; the TTM figure through Dec 2016 stood at $8000.0 (down 42.86% YoY), while the FY2016 annual figure was $4000.0, down 96.83% from the prior year.
  • Notes Payables for Q4 2016 stood at $8000.0, down from $9000.0 in the prior quarter.
  • The five-year high for Notes Payables was $20.6 million in Q4 2012, with the low at $4000.0 in Q1 2016.
  • The 5-year median for Notes Payables is $192000.0 (2014), against an average of $1.9 million.
  • The sharpest annual moves came in 2012 and 2016: Notes Payables jumped 2826.14% in 2012, then sank 96.83% in 2016.
  • VivoSim Labs' Notes Payables stood at $20.6 million in 2012, then slumped by 95.12% to $1.0 million in 2013, then slumped by 70.38% to $298000.0 in 2014, then sank by 95.3% to $14000.0 in 2015, then plunged by 42.86% to $8000.0 in 2016.
  • Business Quant data shows VIVS's Notes Payables at $8000.0 in Q4 2016, $9000.0 in Q3 2016, and $9000.0 in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.79 Bn 130.93 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.99 Bn 78.00 Bn 3.93 Bn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn
4 Moderna 56.04 Bn 50.91 Bn 52.00 Mn
5 BeOne Medicines 42.05 Bn 36.95 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.71 Bn 28.40 Bn 992.69 Mn
7 BioNTech SE 27.66 Bn 9.26 Bn 668.28 Mn
8 Insmed 27.50 Bn 26.33 Bn 358.27 Mn
9 Royalty Pharma 27.35 Bn 26.52 Bn -
10 VivoSim Labs 1.47 Mn 1.47 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 8,000.00
Sep 30, 2016 9,000.00
Jun 30, 2016 9,000.00
Mar 31, 2016 4,000.00
Dec 31, 2015 14,000.00
Sep 30, 2015 16,000.00
Jun 30, 2015 26,000.00
Mar 31, 2015 126,000.00
Dec 31, 2014 298,000.00
Sep 30, 2014 258,000.00
Jun 30, 2014 352,000.00
Mar 31, 2014 377,000.00
Dec 31, 2013 1.01 Mn
Sep 30, 2013 795,000.00
Mar 31, 2013 6.90 Mn
Dec 31, 2012 20.60 Mn
Dec 31, 2011 704,000.00